company logo

Dermatology Therapeutic Specialist at Incyte in Columbus, OH

Incyte
Columbus, OH 43085
clockMore than 4w ago
bookmark emptySave
More info when clicked here
You fill out 1 set of questions 1 time. We take care of your job applications every time you choose Apply4Me.
What's Apply4Me?

compensation:

$80K — $100K *

specialty:

Pharmaceutical/Medical Sales

experience:

Less than 5 years

Job Description

See More arrow

Valid through: 4/12/2021

About Incyte

Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware. The company was founded in Palo Alto, California in 1991 and went public in 1993. Incyte has one drug, Jakafi, which has been approved by the U.S. Food and Drug Administration and has been prescribed to patients in the United States. As of 2014, the company was developing baricitinib, an oral JAK1 and JAK2 inhibitor drug for rheumatoid arthritis in partnership with Eli Lilly. It gained EU approval in February 2017. In April 2017, the US FDA issued a rejection, citing concerns about dosing and safety. As of 2016 epacadostat, an indoleamine 2,3-dioxygenase inhibitor, was in development for various cancers and was in combination trials with Merck's pembrolizumab and Bristol Myers Squibb's nivolumab. In 2013, Novartis acquired Incyte's c-Met inhibitor capmatinib. In 2014, Incyte named Hervé Hoppenot president and CEO. Hoppenot had previously served as the president of Novartis Oncology; he had been with Novartis since 2003. In September 2015, the company announced it had gained exclusive development and commercial right pertaining to Jiangsu Hengrui Medicine Co., Ltd's anti-PD-1 monoclonal antibody, SHR-1210, in a deal worth $795+ million. In January 2020, Incyte signed a collaboration and license agreement for the global development and commercialization of tafasitamab with MorphoSys. On March 3, 2020, the agreement received antitrust clearance and thus became effective.
stats icon
Total Jobs:
158
stats icon
Total Experts:
3
stats icon
Average Pay:
$102,515
stats icon
Total value of jobs:
$16,300,000
stats icon
% Masters:
41%
Learn More About Incyte blue arrow
* Ladders Estimates